Placement of electrode catheters into the coronary sinus during electrophysiology procedures using a femoral vein approach.

sades de pointes due to quinidine: observations in 31 patients. Am Hearf J 1984; 107:425-%30. 2. Roden DM, Woosley RL, Primm RK. Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care. Am Heart J 1986; 111:1088-1093. 3 Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a metaanalysis of randomized control trials. Circulafion 1990,82:110~1116. 4. The Stroke Prevention in Atria1 Fibrillation (SPAF) Investigators. Stroke prevention in atria1 fibrillation study: final results. Circulation 1991;84:527-539. 5. Bazett HC. An analysis of the time-relations of the electrocardiogram. Heart 1920;7:353. 6. Lopez AJ, Harold JG, Rosenthal MC, Oseran DS, Schapira JN, Peter T. QT prolongation and torsades de pointes after administration of trimethoprim-sulfamethoxazole. Am .I Cardinl 1987:59:37&377. 7. Gohn DC, Simmons TW. Polymorphic ventricular tachycardia (torsades de pointes) associated with the use of probucol. N En@ .I Med 1992326: 1435-1436. 8. Sbasberg B, Scharovsky S, Erdberg A, Duffy CE, Lam W, Swiryn S, Agmon I, Rosen KM. Procainamide-induced polymorphous venhicular tachycardia. Am J Cardiol 1981;47:130%1314.